Exchange: NASDAQ·Updated 07:30 PM EDT
UTHR logo

UTHR United Therapeutics Corp

$487.61
$2.63
(0.54%)
Today
Closed $487.61
$0.00
(0.00%)
After Hours
EarningsOct 28
Mkt Cap$21.03B
Vol327,025.00

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
44

Bearish Sentiment

How do you feel about UTHR?

Advertisement|Remove ads.